ライフサイエンスコーパス: carboxyphenyl

1 yrromethene (BODIPY) dyes, specifically 8-(4-carboxyphenyl)-1,3,5,7-tetramethyl-4,4-difluoro-4-bora-3

2 Self-assembly of N,N,N',N'-tetrakis(4-carboxyphenyl)-1,4-phenylenediamine with the help of dif

3 s, CdS quantum dots (QDs), and zinc(II) 5-(3-carboxyphenyl)-10,15,20-(triphenyl)porphyrin (Zn3MCP), h

4 er of 5alpha-cholestane-3,17-diol with 5-(4'-carboxyphenyl)-10,15,20-triphenylporphin (2-alphabeta, 2

5 on of Cu(NO3)2.2.5H2O with the link bis(4-(4-carboxyphenyl)-1H-pyrazolyl)methane (H2bcppm) and shown

6 ot from [(p-cymene)RuCl(2)](2), sodium 4'-(4-carboxyphenyl)-2,2':6',2''-terpyridine ([Na(+)]tpy-PhCOO

7 ytic inhibitors of MIF-2 and identified 4-(3-carboxyphenyl)-2,5-pyridinedicarboxylic acid (4-CPPC) as

8 4-bora-3a,4a-diaza-s-indacene (BDP) and 8-(4-carboxyphenyl)-2,6-diiodo-1,3,5,7-tetramethyl-4,4-difluo

9 azolinones, led to the discovery of (E)-3-(3-carboxyphenyl)-2-(4-cyanostyryl)quinazolin-4(3H)-one (co

10 ZP4 (Zinpyr-4, 9-(o-carboxyphenyl)-2-chloro-5-[2-(bis(2-pyridylmethyl)aminom

11 of six quaternary ammonium salts of 2,4-di-p-carboxyphenyl-2,4-dimethyl pentanone.

12 tely abrogated by a NO quenching agent, 2-(4-carboxyphenyl)-4, 4,5,5-tetramethylimidazoline-1-oxyl 3-

13 ydroxydecanoate and by the NO scavenger 2-(4-carboxyphenyl)-4,4', 5,5'-tetramethylimidazole-1-oxyl-3-

14 not in the presence of the NO scavenger 2-(4-carboxyphenyl)-4,4,5, 5-teramethylimidazoline-oxyl-3-oxi

15 106 min to 18 s; another NO scavenger, 2-(4-carboxyphenyl)-4,4,5, 5-tetramethylimidazoline-1-oxyl-3-

16 ethyl)-isothiourea) or a NO scavenger ([2-(4-carboxyphenyl)-4,4,5, 5-tetramethylimidazoline-1-oxyl-3-

17 ate/ferrous sulfate mixture (MGD-Fe) or 2-(4-carboxyphenyl)-4,4,5, 5-tetramethylimidazoline-1-oxyl-3-

18 glutathione but not by the NO scavenger 2-(4-carboxyphenyl)-4,4,5,5 tetramethylimidazoline 1-oxyl 3-o

19 as the NO inhibitors aminoguanidine and 2-(4-carboxyphenyl)-4,4,5,5-tetra-methylimidazoline-1-oxyl-3-

20 hibitor aminoguanidine and NO scavenger 2-(4-carboxyphenyl)-4,4,5,5-tetramethyl-imidazoline-1-oxyl-3-

21 , a nonspecific DA receptor blocker, or 2-(4-carboxyphenyl)-4,4,5,5-tetramethyl-imidazoline-1-oxyl-3-

22 treatment of rats with the NO scavenger 2-(4-carboxyphenyl)-4,4,5,5-tetramethylimidazole-1-oxyl-3-oxi

23 of NO with nitronyl nitroxides such as 2-(4-carboxyphenyl)-4,4,5,5-tetramethylimidazoline-1-oxyl 3-o

24 tion of the nitric oxide (NO) scavenger 2-(4-carboxyphenyl)-4,4,5,5-tetramethylimidazoline-1-oxyl-3-o

25 ease at 2, 3, and 12 h was inhibited by 2-(4-carboxyphenyl)-4,4,5,5-tetramethylimidazoline-1-oxyl-3-o

26 , as well as with the scavengers of NO, 2-(4-carboxyphenyl)-4,4,5,5-tetramethylimidazoline-1-oxyl-3-o

27 ctor-kappaB (NF-kappaB) activation, and 2-(4-carboxyphenyl)-4,4,5,5-tetramethylimidazoline-1-oxyl-3-o

28 The NO scavengers 2-(4-carboxyphenyl)-4,4,5,5-tetramethylimidazoline-1-oxyl-3-o

29 on of NO production by the NO scavenger 2-(4-carboxyphenyl)-4,4,5,5-tetramethylimidazoline-1-oxyl-3-o

30 Either a scavenger of NO [2-(4-carboxyphenyl)-4,4,5,5-tetramethylimidazoline-1-oxyl-3-o

31 prevented by the nitric oxide scavenger 2-(4-carboxyphenyl)-4,4,5,5-tetramethylimidazoline-1-oxyl-3-o

32 irmed by the addition of the NO scavenger 2-(carboxyphenyl)-4,4,5,5-tetramethyllimidazoline-1-oxyl 3-

33 Pretreatment with 2-(4-carboxyphenyl)-4,5-dihydro-4,4,5,5-tetramethyl-1H-imidaz

34 -1-carboxylate (SHCHC) is converted to 4-(2'-carboxyphenyl)-4-oxobutyrate (o-succinylbenzoate or OSB)

35 ersion of o-succinylbenzoic acid [OSB; 4-(2'-carboxyphenyl)-4-oxobutyric acid], to o-succinylbenzoyl-

36 trogen species (RNS) scavenger, that is, 2-4-carboxyphenyl-4,4,5,5-tetramethylimidazoline-1-oxyl-3-ox

37 shed in the presence of the NO scavenger 2-4-carboxyphenyl-4,4,5,5-tetramethylimidazoline-1-oxyl-3-ox

38 On theoretical grounds, 2-4-carboxyphenyl-4,4,5,5-tetramethylimidazoline-1-oxyl-3-ox

39 ncing, and changes induced by GSNO, GSNO/2-4-carboxyphenyl-4,4,5,5-tetramethylimidazoline-1-oxyl-3-ox

40 use of (*)NO donors, the scavenger CPTIO ([4-carboxyphenyl]-4,5-dihydro-4,4,5,5-tetramethyl-3-oxide),

41 of an organic tracer dye, rhodamine B ([9-(2-carboxyphenyl)-6-diethylamino-3-xanthenylidene]-diethyla

42 em antibiotic, [4R,5S,6S]-3-[[(3S,5S)-5-[[(3-Carboxyphenyl)amino]carbonyl]-3-pyrrolidinyl ]thio]-6-[(

43 include p-thiolphenyl aminomannose (PTAM), p-carboxyphenyl aminomannose (PCAM), 1-deoxy-1-aminomannop

44 nactive ion (Gd) with the 1,2,4,5 tetrakis(4-carboxyphenyl) benzene (TCPB) organic linker.

45 he presence of small amounts of 1,3,5-tris(4-carboxyphenyl)benzene (H(3)BTB) leads to a new crystalli

46 hexagon-shaped linker 1,2,3,4,5,6-hexakis(4-carboxyphenyl)benzene (H(6)cpb) by solvothermal reaction

47 [In3O(btb)2(HCOO)(L)], (H3btb = 1,3,5-tris(4-carboxyphenyl)benzene acid, L = methanol, water, or etha

48 s has been synthesized from 1,2,4,5-tetrakis(carboxyphenyl)benzene and trans-1,2-dipyridylethene stru

49 of the tetratopic ligand 1,2,4,5-tetrakis(4-carboxyphenyl)benzene as a key building block, a permane

50 (6)-MOFs with 1,4-dibromo-2,3,5,6-tetrakis(4-carboxyphenyl)benzene linkers under a variety of conditi

51 sequential deposition of 1,2,4,5-tetrakis(4-carboxyphenyl)benzene to form supramolecular heterostruc

52 tionally chiral linker 1,2,3,4,5,6-hexakis(4-carboxyphenyl)benzene, cpb(6-): [La(2)(cpb)].1.5dmf was

53 n acyl-enzyme intermediate with (i) the meta-carboxyphenyl cephalothin analogue and (ii) the carbapen

54 ructed by first electrochemically reducing 4-carboxyphenyl diazonium salt, which had been electrochem

55 alogue, Sila-PET) esters based on 1,3-bis( p-carboxyphenyl)disiloxane was studied.

56 oamylnitrite resulting in the formation of 4-carboxyphenyl-DWCNTs.

57 MOFs constructed from the linker tetrakis(4-carboxyphenyl)ethylene (TCPE(4-)) that exhibit an unexpe

58 Both Zn2(TCPE) (TCPE = tetrakis(4-carboxyphenyl)ethylene) and Mg(H2DHBDC) (H2DHBDC(2-) = 2

59 2,4-Diamino-[2'-methoxy-5'-(3-carboxyphenyl)ethynylbenzyl]pyrimidine (28), with an IC(

60 c and Tg DHFR, 2,4-diamino-[2'-methoxy-5'-(4-carboxyphenyl)ethynylbenzyl]pyrimidine (29), with the ca

61 anti-TGF antibodies were immobilized onto 4-carboxyphenyl-functionalized SPCEs modified with strepta

62 mate receptor antagonist (RS)-alpha-methyl-4-carboxyphenyl-glycine (MCPG).

63 lography was used to design and evaluate new carboxyphenyl-glycylboronic acid transition-state analog

64 ich the substituent at the 5'-position was a carboxyphenyl group linked to the benzyl moiety by a bri

65 , and poly( p-carboxyphenyl)siloxanes with p-carboxyphenyl groups at 1,1-, 1,3-, 1,5-, and 1,1,1-posi

66 , bpy is 2,2'-bipyridyl and PICH(2) is (2-(4-carboxyphenyl)imidazo[4,5-f][1,10]phenanthroline).

67 MF)(69)(NO(3))(2)](n) (1) {H(2)L = 1,3-bis(4-carboxyphenyl)imidazolium}, has been synthesized under s

68 The 4-carboxyphenyl isomer of 1, in which the carboxylic acids

69 istry between the carboxylic groups of the 4-carboxyphenyl layer and amine groups of the antibody.

70 ochemically generated in situ, to a stable 4-carboxyphenyl layer on carbon nanofiber-modified screen

71 4-carboxyphenyl layers were covalently grafted on the six

72 nal monomer, cytosine-bis(2,2'-bithienyl)-(4-carboxyphenyl)methane ester (Cyt-S4), revealed Watson-Cr

73 tagonist, LY382884 ((3S, 4aR, 6S, 8aR)-6-((4-carboxyphenyl)methyl-1,2,3,4,4a,5,6,7,8,8a-decahydro iso

74 th the antagonist (alphaS)-alpha-amino-3-[(4-carboxyphenyl)methyl]-3,4-dihydro-2,4-dioxo-1(2H)-pyri m

75 s, a chiral cephalothin analogue with a meta-carboxyphenyl moiety corresponding to the C(3)/C(4) carb

76 2P), and Zn(II)-5,10,15,20-tetra(3-ethynyl(4-carboxyphenyl)phenyl)porphyrin (m-ZnTC(PEP)P)) were comp

77 rin (m-ZnTCPP), Zn(II)-5,10,15,20-tetra(3-(4-carboxyphenyl)phenyl)porphyrin (m-ZnTCP2P), and Zn(II)-5

78 rboxyl groups of (R,R)-N,N'-phthaloyl-2,3-(2-carboxyphenyl)-phenyl-3,4-diazaphospholane (1) yields ph

79 nOPPc = zinc(II)-2,3,9,10,16,17,23,24-octa(4-carboxyphenyl)phthalocyanine] PSs supported on the secon

80 hosphorescence quenching of Pd-meso-tetra-(4-carboxyphenyl) porphine by oxygen.

81 g of the phosphorescence of Pd-meso-tetra (4-carboxyphenyl) porphine were determined as a function of

82 on constants determined for Pd-meso-tetra (4-carboxyphenyl) porphine, as measured by two independent

83 The oxygen-sensitive dye, Pd-meso-tetra (4-carboxyphenyl) porphine, bound to bovine serum albumin,

84 hosphorescence quenching of Pd-meso-tetra-(4-carboxyphenyl) porphine, in an airtight chamber that hel

85 hosphorescence quenching of Pd-meso-tetra-(4-carboxyphenyl)porphine by oxygen.

86 Iron(III) meso-tetra(2-carboxyphenyl)porphine chloride (1) was investigated as

87 Tetrakis(4-carboxyphenyl) porphyrin (H(4) TCPP) and 1,3,6,8-tetraki

88 to quantify cellular uptake of meso-tetra (4-carboxyphenyl) porphyrin (TCPP), a porphyrin that is cur

89 the hydrogen-bonding network of tetrakis (4-carboxyphenyl) porphyrin (TCPP).

90 For a single-molecule zinc-tetra (4-carboxyphenyl) porphyrin (ZnTCPP)/TiO(2) nanoparticle sy

91 ectron-cation recombination in zinc-tetra (4-carboxyphenyl) porphyrin (ZnTCPP)/TiO(2) nanoparticle sy

92 Nafion/Fe(III) meso-tetra (4-carboxyphenyl) porphyrin/reduced graphene oxide (Nafion/

93 -thienyl)cyclopentene (BPMTC) and tetrakis(4-carboxyphenyl)porphyrin (H4TCPP) ligands anchored by Zn(

94 phyrin (p-ZnTCPP), Zn(II)-5,10,15,20-tetra(3-carboxyphenyl)porphyrin (m-ZnTCPP), Zn(II)-5,10,15,20-te

95 Zn(II)-porphyrins (Zn(II)-5,10,15,20-tetra(4-carboxyphenyl)porphyrin (p-ZnTCPP), Zn(II)-5,10,15,20-te

96 Aggregates of the diacid form of tetra(p-carboxyphenyl)porphyrin (TCPP) are found to be stabilize

97 In this study, we introduce tetrakis(4-carboxyphenyl)porphyrin (TCPP) as a universal photosensi

98 Via our strategy, tetratopic tetrakis(4-carboxyphenyl)porphyrin (TCPP) ligands were successfully

99 of H(2)TCPP(2+), the diacid form of tetra(p-carboxyphenyl)porphyrin (TCPP).

100 he self-assembly of zinc(II) meso-tetrakis(4-carboxyphenyl)porphyrin (ZnTPPc) at an immiscible aqueou

101 new phosphors, one based on Pd-meso-tetra-(4-carboxyphenyl)porphyrin and the other on Pd-meso-tetra-(

102 talyst was cobalt meso-5,10,15,20-tetrakis(4-carboxyphenyl)porphyrin chloride, Co(TCPP)Cl.

103 cked monolayer of zinc 5,10,15,20-tetrakis(3-carboxyphenyl)porphyrin has been prepared and deposited

104 based signal amplification method to tetra(4-carboxyphenyl)porphyrin nanoparticles (TCPP NPs).

105 amework (MOF), constructed from a tetrakis(4-carboxyphenyl)porphyrin sensitizer and a dipyridyl thiaz

106 dicarboxydiphenyl sulfone, TCPP = tetrakis(4-carboxyphenyl)porphyrin).

107 udies of the uroporphyrin:Cc and tetrakis (4-carboxyphenyl)porphyrin:Cc complexes suggests that side-

108 ganic framework consisting of [5,10,15,20-(4-carboxyphenyl)porphyrin]Co(III) (CoTCPP) struts bound by

109 Four Zn(II)-tetra(carboxyphenyl)porphyrins in solution and bound to metal

110 he broad-range iGluR antagonist (2S,3R)-3-(3-carboxyphenyl)pyrrolidine-2-carboxylic acid (1) by explo

111 The 3-carboxyphenyl ring of 2e and 2f forms contacts comparabl

112 sizing both mono- and di-, tri-, and poly( p-carboxyphenyl)siloxanes with p-carboxyphenyl groups at 1

113 have prepared ruthenium complexes with 4'-(4-carboxyphenyl)terpyridine ligands, and studied reactivit

114 l incorporation of the photoactive bis(4'-(4-carboxyphenyl)-terpyridine)ruthenium(II) (Ru(cptpy)(2))

115 )porphyrin and the other on Pd-meso-tetra-(4-carboxyphenyl)tetrabenzoporphyrin, are very well suited

116 erts p-aminobenzoate (Ar-NH(2), where Ar = 4-carboxyphenyl) to p-nitrobenzoate (Ar-NO(2)) in the bios

117 c-ring-dihydroxylated CBZ (VI) and N,N-bis(2-carboxyphenyl)urea (VII).

118 In contrast, the (3-carboxyphenyl)urea derivative (29, GW7854) had moderatel

119 ex, symmetrical bis-benzimidazoles and a bis-carboxyphenyl were then assayed as fragment-based leads,

120 The optimal N3 substituent had m-carboxyphenyl with a two-carbon alkyl tether.